Aquaphor. http://www.dermstore.com/product_Original+Ointment_433.htm.* |
International Search Report, PCT/US02/24974. |
Brian B. Quebbeman, et al. “Effect of calcitonin gene-related peptide on well-developed canine coronary collateral vasculature,” J. Cardiovascular Pharm., 21 (1993) 774-780. |
Peter R. Ludman, et al., “Effects of calcitonin gene-related peptide on normal and atheromatous vessels and on resistance vessels in the coronary circulation in humans,” Circulation, 84:5 (Nov. 1991) 1993-2000. |
Jacek J. Prieblsz, “Calcitonin gene-related peptide and regulation of human cardiovascular homeostasis,” American J. of Hypertension, 6:5 (May 1993) 434-450. |
Neal G. Uren, et al., Effect of intravenous calcitonin gene-related peptide on ischaemia threshold and coronary stenosis saverity in humans, Cardiovascular Res., 27 (1993) 1477-1481. |
Donald J. DePette and Sunll Wimalawansa, “Cardiovascular actions of calcitonin gene-related peptide,” Calcium Regulating Hormones and Cardiovascular Function, (1994) 239-252. |
Nobuyo Sekiguchi, et al., “Effect of calcitonin gene-related peptide on coronary microvessels and its role in acute myocardial ischemia,” Circulation89:1 (Jan. 1994) 366-374. |
Sunil Wimalawansa, “Calcitonin: Molecular biology, physiology, pathophysiology and its therapeutic uses,” 121-160, not dated. |
Sunil Wimalawansa, “Isolation, purification, and biochemical characterisation of calcitonin gene-related peptide receptors,” Annals New York Academy of Science, 657 (1992) 70-87. |
“Medical Management of Erectile Dysfunction: A Primary-Care Manual”, Harin Padma-Nathan, MD, Professional Communications, Inc., Ed., First edition, Copyright 1999. |
“Erectile Dysfunction: A Clinical Guide”, Roger Kirby, et al., Isis Medical Media Ltd., Ed., 1999. |
Jean McEwan, et al. “Calcitonin gene-related peptide: a potent dilator of human epicardial coronary arteries,” Circulation, 74:6 (Dec. 1986) 1243-1247. |
Michael G. Rosenfeld, et al. “Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing,” Nature, 304:14 (Jul. 1983) 129-135. |
Howard R. Morris, et al. “Isolation and characterization of human calcitonin gene-related peptide,” Nature, 308:19 (Apr. 1984) 746-748. |
P.H. Steenberg, et al. “A second human calcitonin/CGRP gene,” FEBS 183:2 (Apr. 1985) 403-407. |
J.W.M. Hoppener, et al. “The second human calcitonin/CGRP gene is located on chromosome 11, ” Human Genetics 70 (1985) 259-263. |
David Ezra, et al. “Calcitonin gene-related peptide: a potent modulator of coronary flow,” European J. of Pharm., 137 (1987) 101-105. |
T. Shoji, et al., “Vasodilating effects of human and rat calcitonin gene-related peptides in isolated porcine coronary arteries,” Naunyn-Schmiedeberg's Arch Pharmacol., 336 (1987) 438-444. |
J.R. McEwan, et al. “Vasodilatation by calcitonin gene-related peptide and by substance P: a comparison of their effects on resistance and capacitance vessels of human forearms,” Circulation, 77:5 (May 1988) 1072-1080. |
Sunil J. Wimalawansa, et al., “Isolation, purification and characterization of beta-hCGRP from human spinal cord, ” Biochem, and Biophys. Res. Comm., 167:3 (Mar. 1990) 993-1000. |
Sunil J. Wimalawansa, “Use of synthetic peptides in specific affinity chromatography for purification of specific peptide receptors,” Innovation and Perspectives in Solid Phase Synthesis: (Peptides, Polypeptides and Oliconucleotides), (1992) 111-119. |